Prosecution Insights
Last updated: November 15, 2026
Application No. 19/139,323

GASTROENTEROANASTOMOSIS DEVICE

Non-Final OA §101§102§112
Filed
Jun 13, 2025
Priority
Dec 16, 2022 — DK PA 2022 70623 +1 more
Examiner
DORNBUSCH, DIANNE
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Geabetes Aps
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
569 granted / 768 resolved
+4.1% vs TC avg
Strong +35% interview lift
Without
With
+35.2%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
30 currently pending
Career history
798
Total Applications
across all art units

Office Action

§101 §102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 1 is objected to because of the following informalities: on line 2, “the stomach to a target portion of the small” should be -- a stomach to a target portion of a small--. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-23 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the first peripheral portion" in line 18. There is insufficient antecedent basis for this limitation in the claim. It is unclear to the examiner if this is a new component or if applicant is referring to “the first peripheral region” previously claimed. Claim 1 recites the limitation "the engagement region" in lines 23 and 24. There is insufficient antecedent basis for this limitation in the claim. It is unclear if the engagement region is a new limitation or if it is referring to either “the first engagement region”, “the second engagement region”, or “the first and second regions”. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claims 1-23 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). On the last three lines, “a pressure applied to the apposed tissue walls from ischemic pressure at the engagement region to no pressure at the periphery, passing through non-ischemic pressure.”, it appears to the examiner that the tissue wall is positively claimed. For purpose of this action, the limitation will be interpreted as “a pressure configured to be applied to the apposed tissue walls from ischemic pressure at the engagement region to no pressure at the periphery, passing through non-ischemic pressure.” Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-23 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kopelman (2019/0216460). Kopelman discloses the following claimed limitations: Claim 1: A gastroenteroanastomosis device for use in a minimally invasive procedure for forming a passage across apposed tissue walls from the stomach to a target portion of the small intestines in a patient (Fig. 1-2b, [0104], and [0151]); the device being transformable from a collapsed state configured for minimally invasive delivery of the device to a gastro-enteric deployment site in the apposed tissue walls ([0008], [0137], [0146]) to a deployed state configured for deployment at the gastro-enteric deployment site (Fig. 2b and 9a-11); the device comprising when seen in the deployed state: a first part (combination of 202 and 204 as seen in Fig. 2a-b, the two rings that make 406 in Fig, 4a-c, combination of 1110 and 1112 in Fig. 11) adapted for enteric placement (Fig. 2a-b, 4b-c, and Fig. 11); a second part (combination of 203 and 209 as seen in Fig. 2a-b, the two rings that make 408 in Fig, 4a-c, combination of 1100 and 1114 in Fig. 11) adapted for gastric placement (Fig. 2a-b, 4b-c, and Fig. 11); and a centrally arranged connection (240 in Fig. 2b, 410 in Fig. 4a-c, 1122 in Fig. 11) forcing the first and second parts towards each other in an axial direction (Fig. 2b, 4b-c, and 11, [0204], [0225], and [0283]); wherein the first part comprises a first engagement region (202, inner ring in Fig. 4b-c, 1110), wherein the second part comprises a second engagement region (203, inner ring in Fig. 4b-c, 1100) facing towards the first engagement region (Fig. 2a-b, 4b-c, and Fig. 11), and wherein the first and second engagement regions are adapted to engage the apposed tissue walls there between to apply an ischemic pressure (Fig. 2a-b, 4b-c, and Fig. 11, [0158], [0196], and [0274]); wherein the first part further comprises a first peripheral region (204, outer ring in Fig. 4b-c, 1112) enclosing the first engagement region in a peripherally outward direction (Fig. 2a-b, 4b-c, and Fig. 11), wherein the second part further comprises a second peripheral region (209, outer ring in Fig. 4b-c, 1114) enclosing the second engagement region in a peripherally outward direction (Fig. 2a-b, 4b-c, and Fig. 11) and facing towards the first peripheral portion (Fig. 2a-b, 4b-c, and Fig. 11), and wherein the first and second peripheral regions are adapted to contact the apposed tissue walls there between to apply a non-ischemic pressure (Fig. 2a-b, 4b-c, and Fig. 11, [0181], [0221], [0275]); wherein the first and second peripheral regions diverge from each other (Fig. 2a-b, 4b-c, and Fig. 11), whereby the first and second peripheral regions cooperate to gradually reduce, in an outward going direction from the engagement region to a periphery of the device (Fig. 2a-b, 4b-c, and Fig. 11), a pressure applied to the apposed tissue walls from ischemic pressure at the engagement region to no pressure at the periphery, passing through non-ischemic pressure (Fig. 2a-b, 4b-c, and Fig. 11, [0179-0182], [0221], [0274-275]). Claim 2: wherein the distance between the cooperating peripheral regions increases monotonically, or strictly monotonically, from an inner distance at the peripherally outer border of the engagement regions to an outer distance at the peripherally outer border of the peripheral regions (Fig. 2a-b, 4b-c, and Fig. 11). Claim 3: wherein a first one of the first and second cooperating parts has a concave shape facing towards the other one of the first and second parts ([0179]). Claim 4: wherein the other one of the first and second parts has a convex shape facing towards the concave first one of the first and second parts ([0179]). Claim 5: wherein a peripheral contour of the cooperating engagement regions of the first and second parts has a circular shape (Fig. 11-12). Claim 6: wherein a peripheral contour of the cooperating engagement regions of the first and second parts has an elongated shape (Fig. 2a and [0187]). Claim 7: wherein the first part and/or the second part comprises a collapsible frame structure (401 which can be a shape memory material) having a collapsed state adapted for minimally invasive delivery and an expanded state adapted for deployment at the gastro-enteric deployment site ([0011], [0119], [0124], [0130], [0222]). Claim 8: wherein the first part and/or the second part, as applicable, further comprises a foldable membrane (ring around 401 as seen in Fig. 4a) attached to the collapsible frame structure (Fig. 4a), wherein the membrane is folded together when the collapsible frame structure is in the collapsed state, and wherein the membrane is unfolded to present a cooperating surface comprising engagement and peripheral regions, when the collapsible frame structure is in the expanded state ([0011], [0119], [0124], [0130], [0222]). Claim 9: wherein a collapsible structure of the first part and/or the second part is biased towards an expanded state ([0011], [0119], [0124], [0130], [0222] due to the shape memory material). Claim 10: wherein a tip portion (236, 1402) of the first part comprises a cutting device (Fig. 2b and [0196-197] and [0301-302]), such as an electrically heated cutting wire ([0302]). Claim 11: further comprising a sensor element (205) adapted to provide an output indicative of a highest compression force applied between the first part and the second part (Fig. 2b, [0029], and [0192]). Claims 12 and 18: further comprising a sensor element (205) adapted to provide a sensor output indicative of an axial tension forcing the first part and the second part towards each other (Fig. 2b, [0029], and [0192-195]). Claim 13: wherein the sensor element is arranged in the mechanical connection between the first part and the second part (Fig. 2b, [0029], [0141], and [0192-195]). Claims 14 and 20: wherein the device further comprises an indicator device in communication with the sensor element, the indicator device being adapted to produce a user-perceptible output corresponding to the sensor output (Fig. 2b, [0029], [0141], and [0192-195]). Claims 15 and 21: wherein the user-perceptible output is one or more of a visual output ([0194-195] where it is color changing), an audible output, a haptic output, and a tactile output (where it is capable of being one of this) (note that the user-perceptible output is not positively claim) . Claims 16 and 22: wherein the indicator device communicates with the sensor through one or more of a wired connection and a wireless connection ([0194-195 where it is wireless since the change of color is viewed through imaging). Claim 17: further comprising an endoscope (1000, outer tube in Fig. 19) (Fig. 10 and 19, [0191]) adapted for insertion into the stomach at a target site for forming a gastroenteroanastomosis passage (Fig. 10 and 19, [0191]), the endoscope comprising an instrument channel (Fig. 10 and 19, [0191]) extending from a proximal end to a distal end of the endoscope (Fig. 10 and 19, [0191]); an endoscopic catheter (1014, inner tube in Fig. 19) adapted for the delivery and placement of the gastroenteroanastomosis device through the instrument channel of the endoscope (Fig. 10 and 19, [0191], and [0270]). Claim 19: wherein the sensor element is arranged at a proximal end of the endoscope so as to determine an axial tension between a first control element for the manipulation of the first part and a second control element for the manipulation of the second part ([0163] and [0190-191] where the inflation of each ring is controlled separately). Claim 23: wherein the indicator device is arranged at a user end of the endoscope ([0195] which is at the end the image is shown) Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The prior art of record appears to teach the claimed limitations when considered ain combination. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DIANNE DORNBUSCH whose telephone number is (571)270-3515. The examiner can normally be reached Monday-Wednesday 9 am-3 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571) 272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DIANNE DORNBUSCH/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jun 13, 2025
Application Filed
Sep 17, 2026
Non-Final Rejection mailed — §101, §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773202
TISSUE ANCHORS AND TECHNIQUES FOR USE THEREWITH
3y 2m to grant Granted Oct 27, 2026
Patent 12766019
DELIVERY SYSTEM FOR DELIVERING A CARDIOVASCULAR DEVICE
4y 10m to grant Granted Oct 20, 2026
Patent 12765905
Augment Delivery Instrument And Method Of Use
2y 3m to grant Granted Oct 20, 2026
Patent 12758210
AUTOMATIC RELEASE OF A NEAR BONE SUTURE BUTTON FROM A BUTTON INSERTER
2y 2m to grant Granted Oct 13, 2026
Patent 12751711
Variable Density Soft Anchors and Methods of Tissue Repairs
3y 2m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+35.2%)
Low
PTA Risk
Based on 768 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month